Medicenna Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
2026
Medicenna Therapeutics Current Ratio Growth & History (MDNAF)
Medicenna Therapeutics's current ratio was 1.52 for fiscal 2026.
View full Medicenna Therapeutics company overviewMedicenna Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | 1.52 | −4.83 | −76.04% |
| 2025 | 2025-03-31 | 6.35 | −0.31 | −4.67% |
| 2024 | 2024-03-31 | 6.66 | −2.91 | −30.41% |
| 2023 | 2023-03-31 | 9.58 | 0.65 | +7.29% |
| 2022 | 2022-03-31 | 8.92 | −1.34 | −13.04% |
| 2021 | 2021-03-31 | 10.26 | −10.59 | −50.79% |
| 2020 | 2020-03-31 | 20.86 | — | — |
Medicenna Therapeutics quarterly current ratio
Q4.20
Q4.21
Q4.22
Q4.23
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | 1.25 | −3.69 | −74.64% |
| Q4 2026 | 2026-03-31 | 1.52 | −4.83 | −76.04% |
| Q3 2026 | 2025-12-31 | 2.68 | — | — |
| Q2 2026 | 2025-09-30 | 4.01 | — | — |
| Q1 2026 | 2025-06-30 | 4.94 | — | — |
| Q4 2025 | 2025-03-31 | 6.35 | — | — |
| Q4 2023 | 2023-03-31 | 9.58 | 0.65 | +7.29% |
| Q4 2022 | 2022-03-31 | 8.92 | −1.34 | −13.04% |
| Q4 2021 | 2021-03-31 | 10.26 | −10.59 | −50.79% |
| Q4 2020 | 2020-03-31 | 20.86 | — | — |
Medicenna Therapeutics current ratio trends
Over the last five fiscal years, Medicenna Therapeutics's current ratio decreased from 10.26 to 1.52, a change of −8.74. The latest reported quarter, Q1 2027, shows 1.25.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicenna Therapeutics source filings ↗